Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2017 | Moving in the right direction: new possibilities in lymphoma

Wojciech Jurczak • 22 Jun 2017
EHA 2017

Despite there being no ‘breakthrough’ news during June 2017 at the major conferences – ASCO, ICML and EHA – we are making progress. Prof. Wojciech Jurczak from Jagiellonian University, Krakow, Poland, describes the positive steps we’re making for the treatment of lymphomas.

More from Wojciech Jurczak

Nemtabrutinib in R/R follicular lymphoma
1:13
Nemtabrutinib in R/R follicular lymphoma
Wojciech Jurczak • 6 Dec 2025
Bexobrutideg in CLL and approaching the sequencing of BTK degraders and inhibitors
2:20
Bexobrutideg in CLL and approaching the sequencing of BTK degraders and inhibitors
Wojciech Jurczak • 6 Dec 2025
BRUIN CLL-313 results: pirtobrutinib versus BR in patients with treatment-naive CLL/SLL
5:17
BRUIN CLL-313 results: pirtobrutinib versus BR in patients with treatment-naive CLL/SLL
Wojciech Jurczak • 6 Dec 2025
Treating R/R CLL: the value of BTKis and venetoclax
1:59
Treating R/R CLL: the value of BTKis and venetoclax
Wojciech Jurczak • 27 Sep 2024

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals